KYBELLA (Kythera Biopharmaceuticals Inc.)


Welcome to the PulseAid listing for the KYBELLA drug offered from Kythera Biopharmaceuticals Inc.. This Cytolytic Agent [EPC],Decreased Cell Membrane Integrity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Kythera Biopharmaceuticals Inc.
NON-PROPRIETARY NAME: Deoxycholic Acid
SUBSTANCE NAME: DEOXYCHOLIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytolytic Agent [EPC],Decreased Cell Membrane Integrity [PE]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-06-08
END MARKETING DATE: 0000-00-00


KYBELLA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKYBELLA from Kythera Biopharmaceuticals Inc.
LABELER NAME: Kythera Biopharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/2mL)
START MARKETING DATE: 2015-06-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61168-101_674a29b2-5370-4a25-9595-48580e873a2e
PRODUCT NDC: 61168-101
APPLICATION NUMBER: NDA206333

Other DEOXYCHOLIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Kythera Biopharmaceuticals Inc.KYBELLA